Lipids [BR:br08002]
ST Sterol lipids
ST03 Secosteroids
ST0301 Vitamin D2 and derivatives
C08211 Doxercalciferol
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05B ANTI-PARATHYROID AGENTS
H05BX Other anti-parathyroid agents
H05BX03 Doxercalciferol
D01009 Doxercalciferol (USAN/INN) <US>
USP drug classification [BR:br08302]
Metabolic Bone Disease Agents
Vitamin D-related Agents
Doxercalciferol
D01009 Doxercalciferol (USAN/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01607 Vitamin D derivatives
D01009 Doxercalciferol
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Vitamin D3 like receptor
NR1I1 (VDR)
D01009 Doxercalciferol (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01009
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01009